Jeito Capital II's €1B European Biopharma Fund: LPs Back EU Healthcare at Scale
Jeito Capital's €1B Fund II cements the case that Europe can fund late-stage biopharma domestically, without exporting all growth-stage capital to the U.S.
Venture Capital News & Analysis
Funding news, venture capital analysis, investor profiles, and market intelligence.
-
-
KKR's $23B North America PE Fund: Scale Capital Reshapes the Growth-Stage VC Market
Mega buyout funds like KKR's 2026 vehicle aren't traditional VC, but they materially influence late-stage startup exits and crossover rounds.
-
Blackstone's $10B Capital Opportunities V: Private Credit Reshapes the VC Exit Path
Blackstone's opportunistic private credit fund is not VC, but its scale directly changes how venture-backed companies refinance, recapitalize, and exit.
-
Sona's $45M Series B: AI-Native Software for Frontline Operations Keeps Gaining Ground
Sona's April 2026 Series B announcement reflects continued demand for AI systems embedded in workforce and operations workflows.
-
Pumpcade's $1M Pre-Seed: Fast-Resolution Prediction Products Keep Attracting Early Bets
Pumpcade's April 2026 pre-seed round reflects continued investor appetite for experimental fintech and market mechanics products.
-
Moonbounce's $12M Raise: AI Content Moderation Is Becoming Core Runtime Infrastructure
Moonbounce's April 2026 fundraise shows growing demand for policy-aware moderation layers in AI-native products.